نتایج جستجو برای: peptide vaccine

تعداد نتایج: 263016  

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2015
Yoshihiro Yoshitake Daiki Fukuma Akira Yuno Masatoshi Hirayama Hideki Nakayama Takuya Tanaka Masashi Nagata Yasuo Takamune Kenta Kawahara Yoshihiro Nakagawa Ryoji Yoshida Akiyuki Hirosue Hidenao Ogi Akimitsu Hiraki Hirofumi Jono Akinobu Hamada Koji Yoshida Yasuharu Nishimura Yusuke Nakamura Masanori Shinohara

PURPOSE The peptides derived from ideal cancer-testis antigens, including LY6K, CDCA1, and IMP3 (identified using genome-wide cDNA microarray analyses), were used in immunotherapy for head and neck squamous cell cancer (HNSCC). In this trial, we analyzed the immune response to and safety and efficacy of vaccine therapy. EXPERIMENTAL DESIGN A total of 37 patients with advanced HNSCC were enrol...

Journal: :Bioconjugate chemistry 2011
Hilda Garay Tamara Menéndez Yoelys Cruz-Leal Edelgis Coizeau Jesus Noda Vivian Morera Gerardo Guillén Fernando Albericio Osvaldo Reyes

The formulation of a broadly protective vaccine to prevent the serogroup B Neisseria meningitidis (MenB) disease is still an unmet medical need. We have previously reported the induction of bactericidal and protective antibodies against MenB after immunization of mice with a phage-displayed peptide named 4 L-5. This peptide mimics a capsular polysaccharide (CPS) epitope in MenB. With the aim of...

2012
Aleksandra Bartnik Ajit Johnson Nirmal Shi-Yu Yang

Colorectal cancer is the third most common cause of cancer-related deaths and the second most prevalent (after breast cancer) in the western world. High metastatic relapse rates and severe side effects associated with the adjuvant treatment have urged oncologists and clinicians to find a novel, less toxic therapeutic strategy. Considering the limited success of the past clinical trials involvin...

2011
Yoshio Fujita Hiroaki Taguchi

Many studies are currently investigating the development of safe and effective vaccines to prevent various infectious diseases. Multiple antigen-presenting peptide vaccine systems have been developed to avoid the adverse effects associated with conventional vaccines (i.e., live-attenuated, killed or inactivated pathogens), carrier proteins and cytotoxic adjuvants. Recently, two main approaches ...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2021

Significance HIV is a highly mutable pathogen that can mutate to evade vaccine-induced immune responses, thus negating the vaccine’s protective effects. If mutations responses incur fitness penalty for virus, other evolve partially compensate loss. Accounting such effects, we designed single long peptide immunogen comprised of parts proteins wherein would be difficult without penalties virus. T...

Journal: :The Journal of infectious diseases 1999
S Könen-Waisman A Cohen M Fridkin I R Cohen

Healthy persons manifest a high frequency of T cells reactive to epitopes of the self 60-kDa heat-shock protein (hsp60) molecule. It was reasoned that a self hsp60 peptide, p458m, might provide T cell help for a response to the T independent capsular polysaccharide of Streptococcus pneumoniae type 4 (PS4). The conjugate vaccine (PS4-p458m) induced resistance to challenge with >300,000 times the...

2018
Fengbo Wu Yan Huang Peng Zhang Chunting Wang Yaomei Tian Lian Lu Gu He Li Yang

This study presents a rational design approach to discovery synthetic peptide vaccine candidates from endogenous proteins for chronic non-infectious diseases immunological therapeutics. The approach described the screening of key antigenic amino acid residues of the interleukine-13, which is up-regulated expression in asthma, followed by the development of immunological helper epitope peptides ...

2016
Mariusz Skwarczynski Istvan Toth

Classically all vaccines were produced using live or attenuated microorganisms or parts of them. However, the use of whole organisms, their components or the biological process for vaccine production has several weaknesses. The presence of immunologically redundant biological components or biological impurities in such vaccines might cause major problems. All the disadvantageous of traditional ...

2014
Smita K. Nair Georgia D. Tomaras Ana Paula Sales David Boczkowski Cliburn Chan Kelly Plonk Yongting Cai Jens Dannull Thomas B. Kepler Scott K. Pruitt Kent J. Weinhold

Emergence of drug-resistant strains of the pathogen Mycobacterium tuberculosis (Mtb) and the ineffectiveness of BCG in curtailing Mtb infection makes vaccine development for tuberculosis an important objective. Identifying immunogenic CD8+ T cell peptide epitopes is necessary for peptide-based vaccine strategies. We present a three-tiered strategy for identifying and validating immunogenic pept...

Journal: :jundishapur journal of microbiology 0
jale moradi department of microbiology, school of medicine, tehran university of medical sciences, tehran, ir iran mina tabrizi department of medical genetics, school of medicine, tehran university of medical sciences, tehran, ir iran maryam izad department of immunology, school of medicine, tehran university of medical sciences, tehran, ir iran nader mosavari department of tuberculosis, razi vaccine and serum research institute, karaj, ir iran mohammad mehdi feizabadi department of microbiology, school of medicine, tehran university of medical sciences, tehran, ir iran; thoracic research center, imam khomeini hospital, tehran university of medical sciences, tehran, ir iran; department of microbiology, school of medicine, tehran university of medical sciences, tehran, ir iran. tel/fax: +98-2188955810

conclusions the results revealed that the novel multi-epitope dna construct could be an effective candidate in tuberculosis vaccine development, and it is qualified to investigate its potential to induce cd4 and cd8 t- cell immune response in the experimental animal model. results mhc class i-and class ii-predicted epitopes showed a high potential to binding to human hlas alleles, with global b...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید